| Product Code: ETC071578 | Publication Date: Jul 2023 | Updated Date: Jun 2026 | Product Type: Report | |
| Publisher: 6Wresearch | Author: Ravi Bhandari | No. of Pages: 70 | No. of Figures: 35 | No. of Tables: 5 |
The Saudi Arabia Infectious Disease Rapid Diagnostic Testing Market was estimated at USD 201 Million in 2025 and is projected to reach USD 255 Million by 2032, growing at a CAGR of 3.5% from 2026 to 2032. This growth trajectory is attributed primarily to the rising prevalence of infectious diseases in the region, necessitating rapid and accurate testing solutions. The increasing government initiatives aimed at enhancing healthcare infrastructure further bolster the demand for rapid diagnostic tests, essential for effective disease management and outbreak containment.
The Saudi Arabia Infectious Disease Rapid Diagnostic Testing market has witnessed a notable recovery following a challenging decline of -1.6% in 2021, primarily due to the pandemic's initial disruptions. By 2022, the market rebounded impressively with a 6.3% growth, fueled by heightened consumer demand and increased healthcare investments. The trend accelerated in 2023, reaching a robust 10.8%, attributed to advances in technology and a surge in public health initiatives. While growth is projected to stabilize at around 4% through 2032, continuous investments in healthcare infrastructure and digitalization are expected to sustain demand, ensuring resilience against potential market fluctuations. This upward trend reflects an enduring commitment to enhancing diagnostic capabilities within the country.
This graph highlights how the Saudi Arabia Infectious Disease Rapid Diagnostic Testing Market has steadily grown over the past five years, supported by major growth factors.

The table below presents the year‑wise growth rates along with the key drivers influencing the market
| Year | Growth Rate | Major Drivers |
| 2021 | -1.6% | Growing renewable energy integration projects |
| 2022 | 6.3% | Growing renewable energy integration projects |
| 2023 | 10.8% | Increasing adoption of advanced technologies |
| 2024 | 0.9% | Increasing industrial automation investments |
| 2025 | 3.2% | Increasing smart city development projects |
| 2026 | 4.9% | Increasing industrial automation investments |
| 2027 | 3.9% | Rising electricity demand across industries |
| 2028 | 4.6% | Increasing industrial automation investments |
| 2029 | 4.3% | Growing urbanization and commercial development |
| 2030 | 4.2% | Expansion of transportation and logistics networks |
| 2031 | 3.9% | Increasing industrial automation investments |
| 2032 | 3.9% | Growing renewable energy integration projects |
Note - Market size estimations and growth projections presented in this report are based on 6Wresearch’s advanced forecasting approach, validated with industry datasets as of June 2026.
In Saudi Arabia, the urgency of early pathogen detection has made rapid diagnostic tests indispensable, especially during health crises. These tests enable healthcare providers to deliver prompt diagnoses, significantly improving patient outcomes and public health responses. As the nation grapples with various infectious diseases, the reliance on rapid diagnostic testing becomes increasingly critical.
The market has observed heightened demand fueled by both governmental and private sector investments in advanced healthcare technologies. Enhanced testing capabilities not only provide a vital component in managing disease outbreaks but also align with broader public health goals, thereby reinforcing the healthcare system's resilience in Saudi Arabia.
Despite the favorable growth conditions, the Saudi Arabian market faces notable restraints. One significant challenge is ensuring the accuracy of rapid diagnostic tests; false results can compromise patient care and public health initiatives. Moreover, the need for these tests to comply with stringent regulatory standards creates barriers to market entry for new technologies. The industry's reliance on imported products also presents a vulnerability to supply chain disruptions and varying global demand.
Currently, there is a marked trend towards integrating advanced technologies, such as artificial intelligence and machine learning, into rapid diagnostic testing frameworks. These innovations promise improved accuracy and faster results, enhancing the overall efficiency of the healthcare system. Additionally, point-of-care testing continues to gain traction, reflecting a shift towards more accessible testing options for patients in remote areas.
Investors and stakeholders in the healthcare sector can seize multiple opportunities within the infectious disease rapid diagnostic testing market. The ongoing need for rapid testing solutions, amplified by lessons learned during the Covid-19 pandemic, is driving demand for innovative product development. Moreover, partnerships between public health entities and private firms can create pathways for advancing testing technologies while expanding market reach.
The Saudi government has been proactive in enhancing its healthcare infrastructure, making significant investments aimed at combating infectious diseases. Initiatives include funding research for new diagnostic technologies and improving laboratory capabilities. Furthermore, public health campaigns advocating for timely testing and early diagnosis underscore the government's commitment to mitigating the impact of infectious diseases on the population.
Looking ahead to 2026-2032, the Saudi Arabia Infectious Disease Rapid Diagnostic Testing Market is expected to continue its upward trajectory. The emphasis on rapid testing will remain vital, particularly as new infectious diseases emerge. Enhanced collaboration between government bodies, healthcare providers, and technology developers will be crucial in adapting testing capabilities to meet evolving public health needs, ensuring a swift response to future health crises.
Recent developments in the infectious disease rapid diagnostic testing market have centered around the introduction of novel testing technologies and improvements in point-of-care testing methodologies. Companies are increasingly focusing on creating user-friendly testing kits that can deliver results in real-time, facilitating faster patient management. In addition, collaborations between public health authorities and private firms have been instrumental in streamlining regulatory approvals for new rapid diagnostic tests.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Saudi Arabia Infectious Disease Rapid Diagnostic Testing Market Overview |
3.1 Saudi Arabia Country Macro Economic Indicators |
3.2 Saudi Arabia Infectious Disease Rapid Diagnostic Testing Market Revenues & Volume, 2022 & 2032F |
3.3 Saudi Arabia Infectious Disease Rapid Diagnostic Testing Market - Industry Life Cycle |
3.4 Saudi Arabia Infectious Disease Rapid Diagnostic Testing Market - Porter's Five Forces |
3.5 Saudi Arabia Infectious Disease Rapid Diagnostic Testing Market Revenues & Volume Share, By Product, 2022 & 2032F |
3.6 Saudi Arabia Infectious Disease Rapid Diagnostic Testing Market Revenues & Volume Share, By Technology, 2022 & 2032F |
3.7 Saudi Arabia Infectious Disease Rapid Diagnostic Testing Market Revenues & Volume Share, By End-users, 2022 & 2032F |
4 Saudi Arabia Infectious Disease Rapid Diagnostic Testing Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of infectious diseases in Saudi Arabia |
4.2.2 Growing awareness about the importance of early diagnosis and treatment |
4.2.3 Technological advancements in rapid diagnostic testing for infectious diseases |
4.3 Market Restraints |
4.3.1 Limited access to healthcare services in remote areas |
4.3.2 High cost associated with rapid diagnostic testing |
4.3.3 Lack of skilled healthcare professionals for conducting tests |
5 Saudi Arabia Infectious Disease Rapid Diagnostic Testing Market Trends |
6 Saudi Arabia Infectious Disease Rapid Diagnostic Testing Market, By Types |
6.1 Saudi Arabia Infectious Disease Rapid Diagnostic Testing Market, By Product |
6.1.1 Overview and Analysis |
6.1.2 Saudi Arabia Infectious Disease Rapid Diagnostic Testing Market Revenues & Volume, By Product, 2022-2032F |
6.1.3 Saudi Arabia Infectious Disease Rapid Diagnostic Testing Market Revenues & Volume, By Assays, Kits and Reagents, 2022-2032F |
6.1.4 Saudi Arabia Infectious Disease Rapid Diagnostic Testing Market Revenues & Volume, By Instruments, 2022-2032F |
6.1.5 Saudi Arabia Infectious Disease Rapid Diagnostic Testing Market Revenues & Volume, By Services and Software, 2022-2032F |
6.2 Saudi Arabia Infectious Disease Rapid Diagnostic Testing Market, By Technology |
6.2.1 Overview and Analysis |
6.2.2 Saudi Arabia Infectious Disease Rapid Diagnostic Testing Market Revenues & Volume, By Immunodiagnostics, 2022-2032F |
6.2.3 Saudi Arabia Infectious Disease Rapid Diagnostic Testing Market Revenues & Volume, By Clinical Microbiology, 2022-2032F |
6.2.4 Saudi Arabia Infectious Disease Rapid Diagnostic Testing Market Revenues & Volume, By PCR, 2022-2032F |
6.2.5 Saudi Arabia Infectious Disease Rapid Diagnostic Testing Market Revenues & Volume, By INAAT, 2022-2032F |
6.2.6 Saudi Arabia Infectious Disease Rapid Diagnostic Testing Market Revenues & Volume, By DNA Sequencing and NGS, 2022-2032F |
6.2.7 Saudi Arabia Infectious Disease Rapid Diagnostic Testing Market Revenues & Volume, By Other Technologies, 2022-2032F |
6.3 Saudi Arabia Infectious Disease Rapid Diagnostic Testing Market, By End-users |
6.3.1 Overview and Analysis |
6.3.2 Saudi Arabia Infectious Disease Rapid Diagnostic Testing Market Revenues & Volume, By Physician Offices, 2022-2032F |
6.3.3 Saudi Arabia Infectious Disease Rapid Diagnostic Testing Market Revenues & Volume, By Reference Laboratories, 2022-2032F |
6.3.4 Saudi Arabia Infectious Disease Rapid Diagnostic Testing Market Revenues & Volume, By Hospitals, 2022-2032F |
6.3.5 Saudi Arabia Infectious Disease Rapid Diagnostic Testing Market Revenues & Volume, By Academic and Research Institutes, 2022-2032F |
6.3.6 Saudi Arabia Infectious Disease Rapid Diagnostic Testing Market Revenues & Volume, By Others, 2022-2032F |
7 Saudi Arabia Infectious Disease Rapid Diagnostic Testing Market Import-Export Trade Statistics |
7.1 Saudi Arabia Infectious Disease Rapid Diagnostic Testing Market Export to Major Countries |
7.2 Saudi Arabia Infectious Disease Rapid Diagnostic Testing Market Imports from Major Countries |
8 Saudi Arabia Infectious Disease Rapid Diagnostic Testing Market Key Performance Indicators |
8.1 Average turnaround time for test results |
8.2 Number of accredited healthcare facilities offering rapid diagnostic testing |
8.3 Rate of adoption of rapid diagnostic testing technologies |
8.4 Percentage of infectious disease cases diagnosed using rapid tests |
8.5 Level of government funding allocated to improve infectious disease diagnosis and control. |
9 Saudi Arabia Infectious Disease Rapid Diagnostic Testing Market - Opportunity Assessment |
9.1 Saudi Arabia Infectious Disease Rapid Diagnostic Testing Market Opportunity Assessment, By Product, 2022 & 2032F |
9.2 Saudi Arabia Infectious Disease Rapid Diagnostic Testing Market Opportunity Assessment, By Technology, 2022 & 2032F |
9.3 Saudi Arabia Infectious Disease Rapid Diagnostic Testing Market Opportunity Assessment, By End-users, 2022 & 2032F |
10 Saudi Arabia Infectious Disease Rapid Diagnostic Testing Market - Competitive Landscape |
10.1 Saudi Arabia Infectious Disease Rapid Diagnostic Testing Market Revenue Share, By Companies, 2025 |
10.2 Saudi Arabia Infectious Disease Rapid Diagnostic Testing Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here